Article Details

FDA pulls back monoclonal antibodies believed ineffective against Omicron - Politico

Retrieved on: 2022-01-25 20:03:28

Tags for this article:

Click the tags to see associated articles and topics

FDA pulls back monoclonal antibodies believed ineffective against Omicron - Politico. View article details on hiswai:

Excerpt

FDA limits use of two monoclonal antibodies as Omicron dominates U.S. case count. — Pfizer and BioNTech have begun testing an Omicron-specific ...

Article found on: www.politico.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up